January 6, 2025 An opinionated take on NEJM highlights for the fourth quarter of 2024 By Marc Herant NEJM Highlights Read More
October 22, 2024 Working paper: Incentivizing progress, even if small and incremental, in therapies for Alzheimer’s disease should be a priority By Marc Herant Biopharma Read More
October 2, 2024 An opinionated take on NEJM highlights for the third quarter of 2024 By Marc Herant NEJM Highlights Read More
August 8, 2024 A Kaplan-Meier view of oncology development By Marc Herant Biopharma, Consumer Health, Diagnostics, Digital Health, In the News Read More
July 1, 2024 An opinionated take on NEJM highlights for the second quarter of 2024 By Marc Herant NEJM Highlights Read More
April 2, 2024 An opinionated take on NEJM highlights for the first quarter of 2024 By Marc Herant NEJM Highlights Read More
February 7, 2024 Trends in biotech deals in 2022 and 2023: oncology vs. the rest By Marc Herant Biopharma Read More
January 3, 2024 An opinionated take on NEJM highlights for the fourth quarter of 2023 By Marc Herant NEJM Highlights Read More
October 2, 2023 An opinionated take on NEJM highlights for the third quarter of 2023 By Marc Herant NEJM Highlights Read More
July 3, 2023 An opinionated take on NEJM highlights for the second quarter of 2023 By Marc Herant NEJM Highlights Read More
April 20, 2023 An opinionated take on NEJM highlights for the first quarter of 2023 By Marc Herant NEJM Highlights Read More
January 4, 2023 An opinionated take on NEJM highlights for December 2022 By Marc Herant NEJM Highlights Read More
December 4, 2022 Hearts and souls: An opinionated take on NEJM highlights for October and November 2022 By Marc Herant NEJM Highlights Read More
October 2, 2022 Some very disappointing failures: An opinionated take on NEJM highlights for August and September 2022 By Marc Herant NEJM Highlights Read More
September 26, 2022 Trends in oncolytic virus therapeutics: then and now By Marc Herant Biopharma Read More
August 1, 2022 An excellent July vintage: an opinionated take on NEJM highlights for July 2022 By Marc Herant NEJM Highlights Read More
July 1, 2022 An opinionated take on NEJM highlights for June 2022 By Marc Herant NEJM Highlights Read More
June 2, 2022 An opinionated take on NEJM highlights for May 2022 By Marc Herant NEJM Highlights Read More
May 1, 2022 An opinionated take on NEJM highlights for March-April 2022 By Marc Herant NEJM Highlights Read More